Market Overview:
The global oral contraceptive market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and growing demand for oral contraceptives in developing countries. Based on type, the global oral contraceptive market is segmented into combination, progestin only, and others. The combination segment is expected to dominate the market during the forecast period owing to its high efficacy and convenience as compared to other types of contraceptives. Based on application, the global oral contraceptive market is divided into male and female segments. The female segment dominates the overall market due to higher uptake rates for contraception globally as compared to males.
Product Definition:
An oral contraceptive is a medication taken daily to prevent pregnancy. It usually contains a combination of estrogen and progestin, two hormones that work together to prevent ovulation (the release of an egg from the ovary). Oral contraceptives also thicken cervical mucus, making it difficult for sperm to reach the uterus and fertilize an egg.
Combination:
Combination oral contraceptive pills are a combination of more than one type of hormones. The most common types are the progesterone-estrogen combination and the estrogen-progesterone combination. They can also contain other compounds like copper, ethinyl estradiol, or dienogestivenone (DNG). A few brands even include a third hormone called medroxyprogesterone acetate (MPA).
Progestin Only:
Progestin-only (POP) is a type of oral contraceptive that prevents pregnancy by inhibiting the ovaries from releasing an egg. Progestin-only pills contain only one type of hormone, usually progesterone. They do not contain estrogen, which is present in combined oral contraceptives (COCs).
Application Insights:
Based on the application, the global oral contraceptive market is segmented into male and female. The male application segment held a larger share of over 60% in 2017. This is attributed to higher usage rates among males than females worldwide. According to a study published by WHO in 2016, around 9 out of 10 birth control pills are used by men across the world. However, only 6 out of 10 birth control injections are utilized by women globally which points towards huge untapped potential for contraceptives among men worldwide.
The female application segment is expected to witness significant growth over the forecast period owing to increasing awareness about available methods as well as growing acceptance amongst women themselves for using these methods due to increased availability at an affordable cost compared with injectable contraceptives for males only or combined oral contraceptives (COC).
Regional Analysis:
Europe dominated the global oral contraceptive market in 2017. The presence of well-established healthcare infrastructure, high prevalence of infertility and demand for effective contraception are some factors responsible for its large share. In Europe, women between the age group 25 to 34 years have a significantly higher rate of unintended pregnancies than those aged 35 years and above.
The Asia Pacific is expected to be one of the fastest growing regions during the forecast period owing to rising awareness about contraceptives among people in this region as well as increasing access by various government programs such as birth control pills at subsidized rates through AYUSH (Armed Forces) hospitals & clinics along with other initiatives taken by NGOs (Non-Governmental Organizations). China has one of the largest markets due to a large population base that needs contraception; however, it is not easy getting hold off these days due to financial constraints & social stigma attached with it.
Growth Factors:
- Increasing awareness about oral contraceptives and their benefits
- Rising number of women in the workforce
- Growing prevalence of sexually transmitted infections (STIs)
- Increasing use of long-acting reversible contraception (LARCs)
- Proliferation of online pharmacies
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Contraceptive Market Research Report
By Type
Combination, Progestin Only, Others
By Application
Male, Female
By Companies
Pfizer, Inc., Bayer AG, Merck & Co., Inc., Janssen Global Services, LLC, Mankind Pharma Ltd., Teva Pharmaceutical Industries Ltd, Allergan, plc (Actavis), Piramal Enterprises Ltd., Beijing Zizhu Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Oral Contraceptive Market Report Segments:
The global Oral Contraceptive market is segmented on the basis of:
Types
Combination, Progestin Only, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Male, Female
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer, Inc.
- Bayer AG
- Merck & Co., Inc.
- Janssen Global Services, LLC
- Mankind Pharma Ltd.
- Teva Pharmaceutical Industries Ltd
- Allergan, plc (Actavis)
- Piramal Enterprises Ltd.
- Beijing Zizhu Pharm
Highlights of The Oral Contraceptive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Combination
- Progestin Only
- Others
- By Application:
- Male
- Female
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral contraceptives are a type of birth control pill. They work by preventing ovulation (the release of an egg from the ovary). This means that the contraceptive is effective at preventing pregnancy.
Some of the major companies in the oral contraceptive market are Pfizer, Inc., Bayer AG, Merck & Co., Inc., Janssen Global Services, LLC, Mankind Pharma Ltd., Teva Pharmaceutical Industries Ltd, Allergan, plc (Actavis), Piramal Enterprises Ltd., Beijing Zizhu Pharm.
The oral contraceptive market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Contraceptive Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Contraceptive Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Contraceptive Market - Supply Chain
4.5. Global Oral Contraceptive Market Forecast
4.5.1. Oral Contraceptive Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Contraceptive Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Contraceptive Market Absolute $ Opportunity
5. Global Oral Contraceptive Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Contraceptive Market Size and Volume Forecast by Type
5.3.1. Combination
5.3.2. Progestin Only
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Contraceptive Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Contraceptive Market Size and Volume Forecast by Application
6.3.1. Male
6.3.2. Female
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Contraceptive Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Contraceptive Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Contraceptive Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Contraceptive Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Contraceptive Demand Share Forecast, 2019-2026
9. North America Oral Contraceptive Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Contraceptive Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Contraceptive Market Size and Volume Forecast by Application
9.4.1. Male
9.4.2. Female
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Contraceptive Market Size and Volume Forecast by Type
9.7.1. Combination
9.7.2. Progestin Only
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Contraceptive Demand Share Forecast, 2019-2026
10. Latin America Oral Contraceptive Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Contraceptive Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Contraceptive Market Size and Volume Forecast by Application
10.4.1. Male
10.4.2. Female
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Contraceptive Market Size and Volume Forecast by Type
10.7.1. Combination
10.7.2. Progestin Only
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Contraceptive Demand Share Forecast, 2019-2026
11. Europe Oral Contraceptive Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Contraceptive Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Contraceptive Market Size and Volume Forecast by Application
11.4.1. Male
11.4.2. Female
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Contraceptive Market Size and Volume Forecast by Type
11.7.1. Combination
11.7.2. Progestin Only
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Contraceptive Demand Share, 2019-2026
12. Asia Pacific Oral Contraceptive Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Contraceptive Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Contraceptive Market Size and Volume Forecast by Application
12.4.1. Male
12.4.2. Female
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Contraceptive Market Size and Volume Forecast by Type
12.7.1. Combination
12.7.2. Progestin Only
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Contraceptive Demand Share, 2019-2026
13. Middle East & Africa Oral Contraceptive Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Contraceptive Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Contraceptive Market Size and Volume Forecast by Application
13.4.1. Male
13.4.2. Female
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Contraceptive Market Size and Volume Forecast by Type
13.7.1. Combination
13.7.2. Progestin Only
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Contraceptive Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Contraceptive Market: Market Share Analysis
14.2. Oral Contraceptive Distributors and Customers
14.3. Oral Contraceptive Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck & Co., Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Janssen Global Services, LLC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mankind Pharma Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva Pharmaceutical Industries Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Allergan, plc (Actavis)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Piramal Enterprises Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Beijing Zizhu Pharm
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
